We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9983:TSEFAST RETAILING CO., LTD. Analysis

Data as of 2026-05-24 - not real-time

¥75,510.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fast Retailing is trading at ¥75,510, comfortably above its 20‑day SMA of ¥72,862 and the 50‑day SMA of ¥68,999, confirming a short‑term bullish bias despite a bearish MACD histogram and decreasing volume. The RSI sits near 60, indicating momentum is still intact, while the 30‑day volatility of roughly 46% reflects a highly active price environment, yet the computed beta of just 0.05 signals minimal systematic risk. Fundamentally, the company delivers strong top‑line growth of 14.8% YoY, healthy gross and operating margins (54% and 18% respectively), and a robust cash position exceeding ¥2.2 trillion, comfortably covering its modest debt load. However, the DCF‑derived fair value of ¥42,240 and a trailing P/E of 48.5 suggest the stock is currently overvalued relative to earnings. Investors should watch the nearby resistance around ¥75,800 and the bearish MACD signal for any near‑term pull‑back.
Long‑run, Fast Retailing’s high ROE (20.6%), sustainable dividend yield (0.85% with a 37% payout ratio), and global brand expansion provide a compelling growth narrative. The sector’s cyclical nature and modest regulatory exposure keep broader risks in check, while the company’s strong liquidity and low currency exposure further support a favorable outlook. Given the valuation premium, a cautious hold in the short term, transitioning to a buy on any price correction, aligns with the underlying fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price testing resistance near ¥75,800
  • Bearish MACD histogram indicating potential short‑term weakness
  • Decreasing volume trend reducing momentum support

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Robust revenue growth of 14.8% YoY
  • Strong cash generation and low debt‑to‑equity
  • Current valuation premium may lead to price consolidation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings growth and high ROE
  • Dividend sustainability with a low payout ratio
  • Global brand expansion and resilient operating margins

Key Metrics & Analysis

Financial Health

Revenue Growth14.80%
Profit Margin13.06%
P/E Ratio48.5
ROE20.62%
ROA10.03%
Debt/Equity25.41
P/B Ratio8.8
Op. Cash Flow¥781.4B
Free Cash Flow¥474.8B

Technical Analysis

TrendBullish
RSI59.6
Support¥68,580.00
Resistance¥75,800.00
MA 20¥72,862.00
MA 50¥68,999.20
MA 200¥58,430.40
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value¥42,240.13
Target Price¥72,907.14
Upside/Downside-3.45%
GradeOvervalued
TypeGrowth
Dividend Yield0.85%

Risk Assessment

Beta0.05
Volatility46.57%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.